The Claim
In patients with giant Graves' disease, the triple-drug preoperative regimen is associated with a maximum reduction of 63.6% in superior thyroid artery peak systolic velocity, indicating a substantial decrease in thyroid vascularity, which may contribute to reduced intraoperative bleeding risk.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In patients with giant Graves' disease, a combination of three preoperative drugs is linked to a 63.6% decrease in blood flow velocity in the superior thyroid artery, corresponding to reduced thyroid blood supply and lower risk of bleeding during surgery.
See the scientific wording
In patients with giant Graves' disease, the triple-drug preoperative regimen is associated with a maximum reduction of 63.6% in superior thyroid artery peak systolic velocity, indicating a substantial decrease in thyroid vascularity, which may contribute to reduced intraoperative bleeding risk.
High iodine levels block the production and release of thyroid hormones and shrink the blood vessels feeding the thyroid, while supplemental thyroid hormone stops the brain from signaling the thyroid to grow and become more vascular, causing the gland to shrink and become less bloody.
What the research says
1 studyThis study found that giving three specific medicines before surgery to people with a very large overactive thyroid greatly slows down the blood flow in the main artery feeding the thyroid, which likely means less bleeding during the operation.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.